Hancock Whitney’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Hancock Whitney's IDXX Position: Q4 2025 in Review
Hancock Whitney sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 3,133 shares — an estimated $2M sold.
Hancock Whitney first reported a position in IDXX in Q1 2021 and held it in 6 quarters. The position peaked at $2M in Q3 2025. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.
- Hancock Whitney reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
- Hancock Whitney sold 3,133 Idexx Laboratories shares in Q4 2025, an estimated $2M.
- Hancock Whitney first reported a position in Idexx Laboratories in Q1 2021 and held it in 6 quarters.
- Hancock Whitney's Idexx Laboratories position peaked at $2M in Q3 2025.
- 1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.
Based on Hancock Whitney's 13F filing for Q4 2025, filed 17 Feb 2026.